← Evidence map

ReviewFrontiers in oncology2024

Momelotinib - a promising advancement in the management of myelofibrosis in adults with anemia.

Muhammad Furqan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38983933